Tata Chemicals Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/48qilis99ikngdro1trl1oos.pdf

Key Takeaways


Soda Ash Market & Demand

Mukundan: "There is no softening in majority of end use markets as of now. There is a talk of recession, slow down, but this is not being seen by the customers with whom we are interacting, and it continues to be in a very balanced situation to tight situations from market to market."

Regional Margin Walk

Mukundan: "It's a planned shutdown and we had taken a longer outage than normal, mainly because we wanted to have a very, very strong run by Q4 when new prices come in."

Energy Costs & Hedging

Mukundan: "These are not linked as the market price is a function of demand-supply and the cost structures. It is a very specific situation in UK where the energy costs had increased sharply that for visibility with the customer, we are fundamentally moving into a margin structure, but in other markets, it is fundamentally de-linked."

Strategic Moves & Subsidiaries


Volume & Capacity


Guidance & Commitments

CommitmentSpecificsTimeline
US margin accelerationBlended margin to rise on quarterly export resets; domestic and export prices reset even higherQ3 and Q4 FY23
India margin upliftMargin uptake as additional maintenance expenditure drops offQ3 FY23
UK/Kenya margin taperMargins to remain range-bound, maybe tapering down as hedges unwindLater quarters FY23
India demand strengtheningPick-up already seen, should move to stronger levelQ3 into Q4 FY23
India capacity expansionVolume benefit from new capacityBeginning Q1 next fiscal
Silica capacity expansion50,000-ton expansion (2x25,000), funded through internal accrualsExecution to start shortly
Nutraceuticals utilizationGetting closer to full utilization as customer approvals progressEnd of current year
Mithapur steam turbineCommissioning to allow more vacuum salt productionMid-January
CapEx spend₹1,050 crore to be spentH2 FY23 up to H1 FY24
Further capacity expansionPlanning underway across India, US, KenyaAnnouncement shortly
Debt reductionExcess cash to be used to deleverage and pay down debtOngoing
Fresh industry capacityNo major capacity expected before 2026-27 (Inner Mongolia) and closer to 2030 (US)2026-2030

Key Metrics

MetricQ2 FY23
Revenue growth40% YoY over Q2 last year
EBITDA₹920 crore, 84% higher than Q2 last year
India revenue growth40% higher than Q2 last year, driven by higher realizations
UK business profit₹99 crore for the quarter
Rallis international revenue growth67% YoY
Consolidated net debt₹4,409 crore
Consolidated cash₹1,967 crore at end of September
India cash (cash, mutual funds, bank deposits)₹1,365 crore in September
Consolidated CapEx₹304 crore in Q2, against ₹246 crore last year
India standalone CapEx₹220 crore in Q2, against ₹115 crore in Q1
Debt repaid in Q2USD 92 million; total USD 125 million in last six months
Planned volume taken out (India and US shutdowns)~60,000 tons combined
US EBITDA per tonslightly under $50
UK EBITDA per tonalmost in excess of $150
Kenya EBITDA per tonmore than $225
Kenya realizations~$440+ per ton
US realizations$270, up from $200, margins remained $45–$50 per ton range
Maintenance shutdown additional expenditure (US/India)~$3 million–$4 million ahead of normalized number
Last India domestic soda ash price increase1st June; no further changes after July
Landed price correction in some markets~$20 due to freight cost reductions
UK natural gas price index~200, settled at twice pre-conflict normal; spiked to 6x briefly in September
Future CapEx spend (H2 FY23 to H1 FY24)₹1,050 crore to be incurred in next one year
Silica expansion CapEx~₹400 crore, 50,000 tons in two 25,000-ton streams, ~30 months execution
Nutraceuticals plant utilization5,000-ton plant not yet at full utilization
Magadi container volume~300,000 tons annually, ~10% of total company volume
Freight and forwarding charges₹528 crore, up QoQ
Fresh soda ash capacity (Mongolia)~0.1–0.15 crore tons, anticipated closer to '26–'27
US capacity expansion~0.4–0.5 crore tons, now moved to 2030 from initial '27–'28
Mithapur steam turbine commissioningmid-January expected
UK pharmaceutical grade salt project commissioning~18–24 months, civil work started